ROBOTICS & AUTOMATION
Empowering Progress
Up to 25% off Essentials Robotics and Automation titles
Nutritional Management of Renal Disease
- 4th Edition - October 8, 2021
- Editors: Joel D. Kopple, Shaul G Massry, Kamyar Kalantar-Zadeh, Denis Fouque
- Language: English
- Hardback ISBN:9 7 8 - 0 - 1 2 - 8 1 8 5 4 0 - 7
- eBook ISBN:9 7 8 - 0 - 1 2 - 8 1 8 5 4 1 - 4
Nutritional Management of Renal Disease, Fourth Edition, offers in-depth reviews of the metabolic and nutritional disorders prevalent in patients with renal disease and serves… Read more
Purchase options
Institutional subscription on ScienceDirect
Request a sales quoteNutritional Management of Renal Disease, Fourth Edition, offers in-depth reviews of the metabolic and nutritional disorders prevalent in patients with renal disease and serves as an in-depth reference source concerning nutrition and kidney disease. This classic translational reference provides correct diagnosis - and therefore correct treatment - of renal, metabolic, and nutritional disorders. Nephrologists, diebetologists, endocrinologists, dieticians, and nutritionists depend on a strong understanding of the molecular basis for the disease. This fourth edition includes thorough new case reports, offering expert advice on how to use the latest research and clinical findings in counseling patients about dietary and lifestyle options. Readers gain insight into which treatments, medications, and diets to use based on the history, progression, and genetic make-up of a patient.
- Includes the latest comprehensive KDOQI clinical practice guidelines for the nutritional management of kidney disease from the National Kidney Foundation and the Academy of Nutrition and Dietetics, covering recommendations for each essential nutrient, as well as for some nonessential nutrients
- Presents a comprehensive, translational look at all aspects of metabolic and nutritional disorders in one reference
- Provides a common language for nephrologists, nutritionists, endocrinologists, and other interested physicians to assimilate information and discuss the underlying research and translation of best practices for the nutritional management and prevention of renal disease
- Saves clinicians and researchers time in quickly accessing the very latest details on nutritional practice as opposed to searching through thousands of journal articles
Residents/fellows/clinical researchers in nephrology as well as nephrologists, diabetologists, endocrinologists, and nutritionists
- Cover image
- Title page
- Table of Contents
- Copyright
- Dedication
- List of contributors
- About the editors
- Preface
- Part I: Normal and altered metabolism of chronic kidney disease
- Chapter 1. The KDOQI Clinical Practice Guidelines for Nutrition in CKD: 2020 update
- Abstract
- Introduction
- The guideline development process
- Key points addressed in the 2020 updated guideline
- Conclusion
- References
- Chapter 2. The influence of kidney disease on protein and amino acid metabolism
- Abstract
- Introduction
- Influence of protein intake on CKD
- Dietary restriction of protein
- Metabolic acidosis
- Role of protein metabolism in hypertension
- Uremic toxins derived from protein metabolism
- Dysregulation of proteolytic pathways in CKD
- Albumin and other markers of malnutrition
- Protein supplementation in dialysis
- Protein metabolism post-kidney transplantation
- Conclusion
- References
- Chapter 3. Carbohydrate metabolism in chronic renal disease
- Abstract
- Introduction
- Insulin resistance
- Insulin secretion
- Insulin clearance
- Hypoglycemia
- Carbohydrate metabolism in patients with renal replacement therapy
- Treatment of diabetes mellitus in diabetics with chronic kidney disease
- Drug management in diabetics with chronic kidney disease
- References
- Chapter 4. Altered lipid metabolism and serum lipids in chronic kidney disease
- Abstract
- Introduction
- References
- Chapter 5. Energy metabolism and requirements in chronic kidney disease
- Abstract
- Introduction
- Energy balance
- Overview and recommended energy intake in chronic kidney disease patients
- Abbreviations
- References
- Chapter 6. Uremic toxins: an integrated overview of classification and pathobiology
- Abstract
- Introduction
- Definition of a uremic toxin
- Classification of uremic toxins by physicochemical characteristics
- The pathobiologic categorization of uremic toxins according to the processes underlying accumulation in body fluids
- The linkage of uremic toxins to the pathobiology of uremia
- Clinical manifestations of uremia and the role of tropisms
- The effects of diet and dialysis on uremic toxins
- Summary and conclusion
- References
- Chapter 7. Inflammation in chronic kidney disease
- Abstract
- General considerations
- Multifactorial causes of inflammation in chronic kidney disease
- Inflammation as a cause of protein-energy wasting
- Monitoring inflammation
- Treatment of inflammation in chronic kidney disease
- References
- Chapter 8. Catalytic (labile) iron in kidney disease
- Abstract
- Introduction
- Definition of catalytic (labile) iron and its importance in tissue injury
- Role of catalytic iron in acute kidney injury
- Gentamicin-induced mobilization of iron from renal cortical mitochondria
- Evidence suggesting a role for iron in gentamicin-induced acute renal failure in rats
- Catalytic iron in chronic kidney disease
- Concluding comments
- References
- Chapter 9. Carbonyl stress in uremia
- Abstract
- Introduction
- Increased age and other protein modifications
- Carbonyl stress
- Clinical consequences of carbonyl stress
- Nutrition and carbonyl stress
- References
- Chapter 10. Metabolic and nutritional responses to acidemia and alkalemia
- Abstract
- Introduction
- Responses to acute acidemia and alkalemia
- Bone buffering and calcium homeostasis in chronic acidemia
- Increased ammoniagenesis and muscle wasting in acidemia
- Hypoalbuminemia, inflammation, and innate- and cell-mediated immunities
- Endocrine responses to acidemia
- Renal hypertrophy
- What is the benefit of the catabolic response to metabolic acidosis?
- Theories of subclinical acidemia, acid stress, or eubicarbonatemic metabolic acidosis
- Estimated net endogenous acid production and the potential renal acid load
- Clinical implications for calcium and bone
- Clinical implications for protein nutrition, muscle function, and mortality
- Treating metabolic acidosis
- References
- Chapter 11. The gut microbiome and the kidney
- Abstract
- Case vignette
- Introduction to the gut microbiome
- The Gut Microbiome, Dysbiosis, and CKD
- Targeted interventions to treat dysbiosis in CKD/ESRD
- Conclusion and future directions
- References
- Part II: Treatment of altered metabolism in chronic kidney disease
- Chapter 12. Assessment and risk factors for protein-energy wasting and frailty in chronic kidney disease
- Abstract
- Introduction
- Assessment for protein-energy wasting
- Assessment for frailty
- Risk factors of protein-energy wasting and frailty
- Acknowledgments
- Funding sources
- Potential conflict of interests
- Important disclosure
- Abbreviations
- References
- Further reading
- Chapter 13. Causes and treatment of protein-energy wasting in kidney disease
- Abstract
- Introduction
- Causes of protein-energy wasting in chronic kidney disease
- Pathophysiology of protein-energy wasting in chronic kidney disease
- Endocrine and hormonal disorders
- Effect of volume overload
- Contribution of comorbidities
- Altered protein kinetics in chronic kidney disease
- Nutrient loss during dialysis
- Inflammation: agent provocateur of protein-energy wasting
- Role of metabolic acidemia
- Oxidative stress: other key pathways
- Treatment of protein-energy wasting in chronic kidney disease
- Summary and conclusion
- References
- Chapter 14. Prevention and management of cardiovascular disease in kidney disease and kidney failure
- Abstract
- Introduction
- Cardiovascular risk factors
- Management of CVD
- Conclusion
- References
- Chapter 15. Effects of nutritional status and changes in nutrient intake on renal function
- Abstract
- Introduction
- Impact of nutritional status on kidney function
- Impact of protein-energy wasting on kidney function
- Effects of maternal nutrition on renal development
- Conclusion
- References
- Part III: Nutrition and slowing of progressive chronic kidney disease
- Chapter 16. Dietary interventions to slow the progression of chronic kidney disease and improve metabolic control of uremia
- Abstract
- Assessing the progression of chronic kidney disease
- Protein intake and chronic kidney disease: Experimental data
- Dietary protein intake: Clinical studies
- Clinical evidence of the effects of low-protein diets
- Conclusion
- References
- Chapter 17. Disorders of phosphorus homeostasis: emerging targets for slowing progression of chronic kidney disease
- Abstract
- Introduction
- Role of dietary phosphorus intake in disturbances of mineral metabolism in CKD
- Disorders of phosphorus homeostasis and kidney disease progression
- Dietary phosphorus restriction in CKD: practical considerations moving forward
- Conclusion
- References
- Chapter 18. Therapeutic strategies to limit tryptophan metabolites toxicity during chronic kidney disease
- Abstract
- Introduction: Gut-derived uremic toxins
- Metabolism of tryptophan and indole production
- Tryptophan metabolites as aryl hydrocarbon receptor ligands
- Tryptophan metabolites promote CKD progression
- Role of organic anion transporters in the nephrotoxicity of tryptophan metabolites
- Tryptophan metabolites induce a vascular procoagulant phenotype and cardiovascular complications
- Tryptophan metabolites and cardiovascular events in CKD patients
- Tryptophan metabolites involved in musculoskeletal disorders
- Therapeutic strategies to reduce tryptophan metabolites accumulation and production
- Conclusion
- References
- Chapter 19. Alkalization to retard progression of chronic kidney disease
- Abstract
- Introduction
- The daily H+ challenge
- Maintenance of normal acid–base homeostasis
- How might clinicians approach management of H+ stress, as a kidney protective intervention, in individuals with CKD within the context of the three mechanistic strategies?
- Conclusion
- Funding
- References
- Part IV: Mineral and vitamin metabolism in kidney disease
- Chapter 20. Nutritional management of sodium, chloride, and water in kidney disease and kidney failure
- Abstract
- Introduction
- Regulation of sodium, chloride, and water in healthy conditions
- Regulation of sodium, chloride, and water in kidney diseases (stages 3–5)
- Regulation of sodium and water balance in kidney failure (CKD stage 5D)
- Clinical implications of salt and water excesses in kidney diseases
- Recommendations for the nutritional management of sodium, chloride, and water
- Conclusion
- References
- Chapter 21. Management of potassium in chronic kidney disease and acute kidney injury
- Abstract
- Potassium balance in health
- Potassium balance in kidney disease
- Assessing potassium disorders
- Managing hyperkalemia
- Managing hypokalemia
- Case study—hyperkalemia in chronic kidney disease
- References
- Chapter 22. Magnesium and kidney disease
- Abstract
- Introduction
- Serum magnesium in chronic kidney disease
- Modulation of serum magnesium in chronic kidney disease patients
- Magnesium and outcomes
- Nutritional aspects
- Conclusion
- References
- Chapter 23. Calcium, phosphate, PTH, vitamin D, and FGF-23 in CKD-mineral and bone disorder
- Abstract
- Calcium metabolism
- Vitamin D
- Phosphate metabolism
- Parathyroid hormone
- Fibroblast growth factor-23 and Klotho
- Alterations in mineral metabolism in CKD
- Control of serum phosphate in CKD
- Therapy with vitamin D sterols
- Calcimimetics
- Parathyroidectomy
- Conclusion
- References
- Chapter 24. Phosphorus metabolism and fibroblast growth factor 23 in chronic kidney disease
- Abstract
- Phosphate metabolism in health
- Phosphate metabolism in chronic kidney disease
- FGF23’s structure, synthesis, and function
- FGF23 in chronic kidney disease
- Role of phosphate and FGF23 excess
- Interventions to target lowering of phosphate and FGF23
- Summary
- References
- Chapter 25. Vitamin D in kidney disease
- Abstract
- Introduction
- Normal vitamin D metabolism and functions
- Vitamin D physiology in CKD
- Detailed sources of vitamin D and burden of vitamin D deficiency
- Outcomes associated with vitamin D deficiency
- Supplementation of vitamin D
- Vitamin D supplementation in special CKD populations
- Current controversies and summary recommendations
- References
- Chapter 26. Vitamin metabolism and requirements in chronic kidney disease and kidney failure
- Abstract
- Vitamin A, physiology, biochemistry, and nutritional status in chronic kidney disease patients
- Vitamin E, physiology, biochemistry, and nutritional status in chronic kidney disease patients
- Vitamin K, physiology, biochemistry, and nutritional status in chronic kidney disease patients
- Vitamin B1 (thiamine), physiology, biochemistry, and nutritional status in chronic kidney disease patients
- Vitamin B2 (riboflavin), physiology, biochemistry, and nutritional status in chronic kidney disease patients
- Vitamin B6 (pyridoxine) physiology, biochemistry, and nutritional status in chronic kidney disease patients
- Vitamin C (ascorbic acid), physiology, biochemistry, and nutritional status in chronic kidney disease patients
- Folate (vitamin B9), physiology, biochemistry, and nutritional status in chronic kidney disease patients
- Vitamin B12, physiology, biochemistry, and nutritional status in chronic kidney disease patients
- Niacin (vitamin B3) physiology, biochemistry, and nutritional status in chronic kidney disease patients
- Biotin (vitamin B8) physiology, biochemistry, and nutritional status in chronic kidney disease patients
- Pantothenic acid (vitamin B5) physiology, biochemistry, and nutritional status in chronic kidney disease patients
- General comments regarding vitamin supplements in kidney disease
- Conclusion
- References
- Chapter 27. Trace elements, toxic metals, and metalloids in kidney disease
- Abstract
- Introduction
- Trace elements
- Trace element functions
- Overview of trace elements in kidney disease
- Conclusion
- References
- Part V: Nutritional management of clinical conditions associated with kidney disease
- Chapter 28. Nutritional and nonnutritional management of the nephrotic syndrome
- Abstract
- Introduction
- Albumin homeostasis in the nephrotic syndrome
- Dietary protein
- Effects of the nephrotic syndrome on solid tissue proteins
- Dietary proteins as potential allergens responsible for renal disease
- Effects of lipids on renal disease and nephrotic syndrome
- Derangements in divalent cation metabolism in the nephrotic syndrome
- Derangements in salt and water metabolism in the nephrotic syndrome (volume homeostasis)
- Recommendations for nutritional and nonnutritional treatment of the nephrotic syndrome
- References
- Chapter 29. Nutritional approaches and plant-dominant diets for conservative and preservative management of chronic kidney disease
- Abstract
- Introduction
- Dietary protein in kidney disease
- High-protein diets may be harmful to kidney health
- An LPD preserves kidney function
- Plant-based foods have a favorable impact on kidney health
- Benefits of a plant-dominant LPD
- Features of PLADO regimens
- Safety and adequacy of a PLADO
- Impact of PLADO on microbiome in CKD
- Similarities and distinctions between PLADO and other CKD diets
- Role of dietitians in PLADO
- Recommendations for practical implementation of PLADO
- Concurrent pharmacotherapy and other interventions
- Laboratory tests for nutritional management of CKD
- Suggested self-administered questionnaires
- Diet safety and transient dietary regimen suspension
- Challenges and pitfalls of the dietary management of CKD
- Dietary sodium and fluid intake
- Dietary potassium
- Dietary phosphorus
- Dietary calcium and vitamin D
- Vegetarian diet, fibers, and the microbiome
- Carbohydrates, fats, and dietary energy
- Dietary management of acidosis in kidney disease
- Trace elements and vitamins
- Management of weight and CV risk
- Conclusion and practice strategies
- Conflicts of interest
- References
- Chapter 30. Use of dietary therapy in far-advanced chronic kidney disease to delay renal replacement therapy or facilitate incremental dialysis transition
- Abstract
- Introduction
- Protein intake
- Energy intake
- Importance of monitoring the patient
- Benefit beyond dialysis initiation
- Dietary therapy for incremental or infrequent dialysis
- Future directions
- References
- Chapter 31. Nutritional management of maintenance hemodialysis patients
- Abstract
- Introduction
- Assessment of nutritional status in maintenance hemodialysis patients
- Acidemia and protein wasting
- Goals of nutritional management in maintenance hemodialysis patients
- Dietary nutrient requirements
- References
- Chapter 32. Nutritional management of chronic peritoneal dialysis patients
- Abstract
- Introduction
- Main nutritional disturbances in patients undergoing peritoneal dialysis
- Assessment of nutritional status in peritoneal dialysis patients
- Nutritional counseling and recommendations for peritoneal dialysis patients
- Healthy diet for peritoneal dialysis patients: an important concept that has been neglected in the renal diet
- Conclusion
- References
- Further readings
- Chapter 33. Nutritional management of kidney transplantation
- Abstract
- Introduction
- Pretransplant factors affecting posttransplant outcomes
- Nutritional considerations for kidney transplant recipients
- Other nutritional issues
- Current trends and latest topics of interest
- Conclusion
- References
- Chapter 34. Nutritional management of the child with kidney disease
- Abstract
- Etiology of malnutrition
- Assessment of nutritional status
- Nutritional requirements
- Bone mineral metabolism
- Acid–base and electrolytes
- Vitamins and micronutrients
- Nutrition management
- References
- Chapter 35. Metabolic management and nutritional support in acute kidney injury
- Abstract
- Introduction
- Metabolic management in the prevention of AKI and the therapy of AKI/risk stage AKI-1
- Nutrition in the prevention of AKI and therapy of AKI-1
- Metabolic support in AKI stages 2 and 3 without the need for renal replacement therapy
- Nutrition support
- Metabolic management and nutritional support in patients with AKI-3 (and CKD-5) requiring renal replacement therapy (AKI-3D)
- Metabolic alterations specifically induced by acute renal dysfunction
- Carbohydrate metabolism
- Lipid metabolism
- Micronutrients and the antioxidant system in acute kidney injury
- Water-soluble vitamins
- Lipid-soluble vitamins
- Trace elements
- Other electrolytes
- Effect of renal replacement therapy on body metabolism and nutrient balances
- The role of nutritional status and nutrient supply on clinical outcome
- Practical issues concerning clinical nutrition in patients with AKI-3 requiring RRT
- Oral nutrition in patients with acute kidney injury
- Enteral nutrition
- Parenteral nutrition in acute kidney injury
- Complications of nutritional support in patients with acute kidney injury
- Monitoring nutritional support in patients with acute kidney injury
- References
- Chapter 36. Nutritional prevention and treatment of urinary tract stones
- Abstract
- Epidemiology of stones
- Risk factors
- The gut microbiome
- Stone formation
- Goals for the treatment of recurrent stone formers
- Dietary management of idiopathic hyperoxaluria
- Management of secondary hyperoxaluria
- Uric acid stones
- Cystine stones
- Special considerations for stone formers
- References
- Chapter 37. Nutrition and blood pressure
- Abstract
- Introduction
- Obesity and energy intake
- Individual nutrients, miscellaneous substances, and blood pressure
- Dietary, surgical, and lifestyle strategies to prevent or treat hypertension
- Conclusion and recommendations
- Key points
- References
- Chapter 38. Nutrition and anemia in chronic kidney disease
- Abstract
- Prevalence and importance of anemia in chronic kidney disease
- Causes of anemia in CKD
- Mechanisms of anemia and hypoxia-inducible factor pathway in CKD
- Iron homeostasis
- HIF pathway and iron homeostasis
- Altered iron balance and iron homeostasis in CKD
- Evaluation of iron status in CKD
- Iron deficiency
- Associations between iron deficiency and clinical outcomes
- Iron management in CKD
- Oral and IV iron
- Potential risks of iron
- Effects on iron on CKD–mineral bone disease
- Management of renal anemia
- Initiation and maintenance treatment with ESA
- Contributions of various other nutrition factors relating to anemia in CKD
- Vitamin B12
- Vitamin B6
- Declaration of conflict of interest
- References
- Part VI: Obesity, Metabolic Syndrome and Diabetes Mellitus
- Chapter 39. Metabolic syndrome and kidney disease
- Abstract
- Introduction
- Metabolic syndrome and its origins
- Metabolic syndrome and its definition
- Metabolic syndrome and comorbidities
- Chronic kidney disease
- Treatment of metabolic syndrome
- References
- Chapter 40. Nutritional and metabolic management of obesity and the metabolic syndrome in patients with chronic kidney disease
- Abstract
- Introduction
- Magnitude of the obesity crisis
- Defining obesity in persons with chronic kidney disease
- Clinical indicators of kidney disease in obese individuals
- The metabolic syndrome
- Obesity and risk for chronic kidney disease
- The obesity paradox
- Obesity-related kidney disease
- Management of obesity-related kidney disease
- Medications
- Medical and lifestyle interventions
- Surgical weight loss
- Relationship between weight loss and renoprotection
- Management of the metabolic syndrome
- Knowledge gaps
- References
- Chapter 41. Bariatric surgery and kidney disease
- Abstract
- Magnitude of the obesity problem
- Pathogenesis of obesity
- Role of bariatric surgery
- Bariatric operations
- Outcomes of bariatric surgery
- Complications of bariatric surgery
- Postbariatric surgery dietary management
- Role of bariatric surgery in chronic kidney disease
- Role of bariatric surgery in kidney transplant
- Cost/benefit bariatric surgery
- References
- Chapter 42. Nutritional and metabolic management of the diabetic patient with chronic kidney disease and chronic renal failure
- Abstract
- Introduction
- Glucose/insulin homeostasis
- Value of glycemic control and its determination in CKD
- Hypoglycemia
- Diabetes/bone and mineral metabolism
- Dietary protein intake and diabetic kidney disease
- Salt intake and diabetic kidney disease
- References
- Chapter 43. Fructose: a lipogenic nutrient implicated in metabolic syndrome and chronic kidney disease
- Abstract
- Sources of fructose
- Metabolism of fructose
- Fructose as a potential cause of hypertension, obesity, and metabolic syndrome
- Fructose as a mediator of kidney diseases
- Fructose and uric acid
- Renal handling of fructose in subjects with chronic kidney disease and dialysis
- Guideline for fructose intake in chronic kidney disease patient
- Conclusion
- References
- Part VII: Special techniques for delivery of nutrients
- Chapter 44. Oral and enteral supplements in kidney disease and kidney failure
- Abstract
- Introduction
- Advanced CKD [Stages G3B-G5 (nondialysis)]
- Chronic dialysis patients (Stage G5)
- Treatment of patients with ONS and EN
- Provision of ONS during the hemodialysis treatment
- Nephrotic syndrome
- Conclusion
- Acknowledgment
- References
- Chapter 45. Intradialytic parenteral nutrition, intraperitoneal nutrition, and nutritional hemodialysis
- Abstract
- Introduction
- Intradialytic parenteral nutrition
- Advantages and disadvantages of intradialytic parenteral nutrition
- Considerations for intradialytic parenteral nutrition prescription by health-care workers in the United States
- Nutritional hemodialysis and intraperitoneal nutrition
- References
- Chapter 46. Nutritional management of patients treated with continuous renal replacement therapy
- Abstract
- Introduction
- Continuous renal replacement therapy overview
- Continuous renal replacement therapy’s components and their implications for nutritional support
- Implications for nutritional support
- Sodium and fluid balance
- Electrolytes and minerals
- Micronutrients
- Conclusion
- References
- Chapter 47. Motivating the patient with kidney disease to nutrition adherence and other healthy lifestyle activities
- Abstract
- Introduction
- What is motivational interviewing?
- What is not motivational interviewing?
- Four motivational interviewing processes
- Strategies
- Handling sustain talk and discord
- Empirical support
- Applications in kidney disease management
- Learning motivational interviewing
- Dissemination of motivational interviewing
- Conclusion
- Acknowledgment
- References
- Chapter 48. Anorexia and appetite stimulants in chronic kidney disease
- Abstract
- General considerations
- Normal regulation of the feeding–hunger cycle
- Methods of appetite assessment in studies involving patients with chronic kidney disease
- Prevalence of anorexia and clinical implications in patients with chronic kidney disease
- Pathogenesis of anorexia in chronic kidney disease
- Treatment of anorexia in chronic kidney disease
- Conclusion
- References
- Chapter 49. Herbal supplements in patients with kidney disease
- Abstract
- Introduction
- Acute kidney injury
- References
- Chapter 50. Drug–nutrient interactions in renal failure
- Abstract
- Introduction
- Effect of food intake on drug absorption
- Effects of nutrients on drug metabolism
- Nutrients and urinary excretion of drugs
- Interactions of food supplements with drugs
- Drug-induced nutritional deficiencies
- Nutrient interactions with some itemized drugs
- Nutrient interactions with oral anticoagulants
- Nutritional implications of excipients in drugs
- Enteral tube feeding and oral drug administration
- References
- Part VIII: Prevention of frailty and improvement of physical performance
- Chapter 51. Exercise training for individuals with advanced chronic kidney disease
- Abstract
- Introduction
- Impaired physical capability of advanced CKD patients
- Demonstrated value of exercise and physical activity for people with CKD
- Principles of exercise training
- Application of exercise training program design for patients with CKD
- Risks of exercise in the advanced CKD patient
- Safety and contraindications for exercise
- Urgent need for development of renal rehabilitation programs
- Summary
- References
- Chapter 52. Anabolic and anticatabolic agents in kidney disease and kidney failure
- Abstract
- Introduction
- Anabolic mechanisms and pathways
- Catabolic mechanisms and pathways
- Myostatin
- GH and IGF-1
- Vitamin D
- Vitamin D deficiency and muscle function
- Vitamin D and muscle in CKD
- Testosterone
- References
- Chapter 53. Nonnutritional and nonhormonal methods to affect muscle strength and physical performance
- Abstract
- Neuromuscular electrical stimulation
- Effects of electrotherapy for pain in end-stage renal disease patients
- Whole-body vibration training
- References
- Index
- No. of pages: 1040
- Language: English
- Edition: 4
- Published: October 8, 2021
- Imprint: Academic Press
- Hardback ISBN: 9780128185407
- eBook ISBN: 9780128185414
JK
Joel D. Kopple
Joel D. Kopple, MD, editor of the book’s first three editions, is Professor Emeritus of Medicine and Public Health at the David Geffen School of Medicine at UCLA and UCLA Fielding School of Public Health, Los Angeles, CA, and is a member of the Division of Nephrology and Hypertension and The Lundquist Institute at Harbor-UCLA Medical Center, Torrance, California. Dr. Kopple was Chief of the Division of Nephrology and Hypertension at Harbor-UCLA Medical Center from 1982 to 2007. He has published over 600 scientific papers and book chapters and has edited or coedited 15 seminars and proceedings. Dr. Kopple is a former president of the National Kidney Foundation (NKF), the American Society of Parenteral and Enteral Nutrition, the International Society for Renal Nutrition and Metabolism, and the International Federation of Kidney Foundations and was a founder of World Kidney Day.
Affiliations and expertise
The Lundquist Institute at Harbor-UCLA Medica Center, David Geffen School of Medicine at UCLA and UCLA Fielding School of Public Health, Torrance and Los Angelese, CA, United StatesSM
Shaul G Massry
Shaul G. Massry, MD, editor of the book’s first three editions, is Professor Emeritus of Medicine and Physiology and Biophysics at the Keck School of Medicine, University of Southern California, Los Angeles, California. He served as Chief of its Division of Nephrology from 1974 to 2000. He has published over 600 scientific papers and over 80 book chapters, and he is editor or coeditor of 28 books. Dr. Massry has received honorary doctorates from 14 universities across Europe, including the oldest and prestigious Charles University (Prague, Czech Republic), The University of Bologna (Italy), and the University of Padua (Italy). Dr. Massry is a former president of the National Kidney Foundation (NKF).
Affiliations and expertise
Professor of Medicine, Physiology and Biophysics, University of Southern of California, Los Angeles, CA, United StatesKK
Kamyar Kalantar-Zadeh
Kamyar Kalantar-Zadeh, MD, PhD, MPH, editor of the book’s third edition and an Editor-in-Chief of the Journal of Renal Nutrition, is Professor of Medicine, Pediatrics, Public Health and Nursing Sciences, and Chief of Nephrology, University of California Irvine School of Medicine, Irvine, CA; Adjunct Professor of Epidemiology, UCLA Fielding School of Public Health, Los Angeles, CA; and a staff physician in Veterans Affairs Hospital, Long Beach, CA. Dr. Kalantar is a former president of the International Society for Renal Nutrition and Metabolism and the International Federation of Kidney Foundations, co-chair of the joint steering committee of World Kidney Day, and Chair of the Medical Advisory Committee of the National Forum of the ESRD Networks. He has served as PI of a dozen National Institutes of Health grants and has coauthored over 800 manuscripts in peer-reviewed journals.
Affiliations and expertise
University of California Irvine School of Medicine, Orange, CA, USDF
Denis Fouque
Denis Fouque, MD, PhD, is Professor of Nephrology at the University Claude Bernard Lyon1 and Chief of the Division of Nephrology, Dialysis and Nutrition at Lyon-Sud Hospital in Lyon, France. He conducts research in nutrition and metabolism in kidney diseases and in evidence-based nephrology. He was the founder Editor of the Renal Cochrane Collaboration. He was Research Vice-President Health Affairs at the University Claude Bernard Lyon1. He is a former President of the International Society for Renal Nutrition and Metabolism, former Editor-in-Chief of the Journal of Renal Nutrition, and current Editor-in-Chief of Nephrology Dialysis Transplantation. He has coauthored over 400 manuscripts in peer-reviewed journals and 25 book chapters.
Affiliations and expertise
CarMeN Laboratory, INSA-Lyon, INSERM U1060, INRA, University Claude Bernard Lyon 1, Villeurbanne, France;
Department of Nephrolofy, Nutrition and Dialysis, Hospital Lyon-Sud, Hospices Civils de Lyon and University Claude Bernard Lyon 1, Lyon, FranceRead Nutritional Management of Renal Disease on ScienceDirect